Arefeh Khosravi et al. 2022. Biological Evaluation of New Oxadiazole-Based Synthetic α-glycosidase Inhibitors for Hyperglycemia Management: A Research Study: New Oxadiazoles act as a-glycosidase inhibitor. Iranian Journal of Pharmaceutical Sciences. 18, 1 (Jan. 2022), 65–75. DOI:https://doi.org/10.22037/ijps.v18.41378.